Clinical trial
Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
NCT02408744 is registered in ClinicalTrials.gov with University of Guadalajara as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
- Lead sponsor
- University of Guadalajara
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- September 30, 2013
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, fibrosis